Qiagen N.V. (QGEN): Revenue Growth QoQ

QGEN (Qiagen NV) - company brandmark

The stability of Qiagen N.V. (QGEN) is based on the sale of consumables and EBIT margins. Quarterly revenue changes reflect market expectations, where the 2.80 level captures the latest values. Leadership in DNA testing and digital PCR is driving the growth in share prices. The asset remains independent of economic cycles, relying on the rollout of innovative medical developments.

QGEN (Qiagen NV) Revenue Change vs Previous Quarter history from 07/04/2022 to 11/21/2026

Financial and market metric breakdowns for Qiagen (QGEN)

- share price and expert price forecast:
Fundamental valuation:QGEN - Qiagen
Mass-produced product of qiagen.com

Quarterly revenue growth measures the dynamics of cash inflows for the current period relative to the same quarter of the previous year. The magnitude of quarterly revenue growth allows an investor to assess the actual speed of business scaling by filtering out seasonal fluctuations. This metric is calculated as the percentage change in sales volume, reflecting the effectiveness of the commercial strategy. For Qiagen N.V. (QGEN), this indicator confirms the impact of capacity modernization and the expansion of cleanrooms on meeting global medical demand.

Direct competitors

TEM - Revenue Growth QoQ|Ionis Pharmaceuticals (IONS) - Quarterly Sales Growth|Repligen (RGEN) - Revenue Growth QoQ|Quarterly Sales Growth Avidity Biosciences, Inc.|Revenue Growth QoQ CRISPR Therapeutics|WGS - Revenue Change vs Previous Quarter|Quarterly Revenue Growth RARE|Sales Change QoQ BEAM|Quarterly Revenue Growth SRPT (Sarepta Corp)|TWST - Quarterly Sales Growth|TXG: Quarterly Sales Growth|Quarterly Revenue Growth Rate Intellia Therapeutics|STOK: Quarterly Revenue Growth|BLFS - Quarterly Sales Growth Rate|Quarterly Sales Growth WVE|MAZE: Quarterly Revenue Increase|Revenue Growth QoQ Sionna Corp (SION)|Quarterly Sales Growth Rate Prime Medicine Bio|Quarterly Revenue Growth TSHA (Taysha Gene Therapies Inc)|Quarterly Revenue Growth uniqure.com QURE|MeiraGTx Holdings - Quarterly Revenue Growth|RGNX - Quarterly Revenue Growth|SLDB (Solid Corp) - Quarterly Sales Growth|Revenue Change vs Previous Quarter Ocugen Corp OCGN|PACB (Pacific Biosciences) - Quarterly Revenue Growth|Revenue Growth QoQ BNTC|Quarterly Revenue Growth DSGN|Quarterly Sales Growth Rocket Pharma RCKT|Quarterly Sales Growth Rate FDMT|Quarterly Revenue Growth Lexeo Therapeutics LXEO|KRRO - Revenue Growth QoQ|EDIT (Editas Medicine, Inc.) - Sales Growth QoQ|SLN: Quarterly Revenue Growth|ProQR - Quarterly Revenue Increase|CDXS (Codexis) - Quarterly Revenue Growth|Sangamo (SGMO) - Quarterly Sales Growth Rate|Quarterly Revenue Growth NAUT|Quarterly Sales Growth Metagenomi, Inc. MGX|Revenue Growth QoQ Precision BioSciences DTIL|Quarterly Revenue Increase GBIO|BOLD - Revenue Growth QoQ|Quarterly Sales Growth Rate Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Revenue Growth QoQ|RXi Pharmaceuticals - Quarterly Revenue Increase|MBIO (Mustang Bio) - Quarterly Revenue Growth|Sales Growth QoQ RNAZ (transcodetherapeutics.com)|Revenue Growth QoQ Bionano (BNGO)|Applied DNA Sciences - Sales Growth QoQ|Quarterly Revenue Growth BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Quarterly Revenue Growth Rate|omegatherapeutics.com - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Singular Genomics Systems Inc (OMIC)|RGLS: Quarterly Revenue Growth|Syros Pharmaceuticals, Inc (SYRS) - Quarterly Revenue Growth|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)